About Sinovac
Sinovac is a company based in Haidian (China) founded in 2001 was acquired by SAIF Partners in June 2017. Sinovac operates in a competitive market with competitors including Adaptive Biotechnologies, Moderna, Generate Biomedicines, HOOKIPA Pharma and Brii Biosciences, among others.
- Headquarter Haidian, China
- Stage Public
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
$515 M (USD), Post-IPO
Dec 07, 2020
-
Investors
Sino Biopharmaceutical
& 7 more
-
Employee Count
Not available
-
Acquired by
SAIF Partners
(Jun 26, 2017)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Sinovac
Investors in Sinovac
Sinovac has secured backing from 6 investors, including institutional and venture fund investors. Prominent investors backing the company include Sino Biopharmaceutical, Advantech Capital and Vivo Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Locked | Locked | Locked | |
|
Venture capital and private equity firm
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked |
Investor details for Sinovac
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Sinovac
Investment portfolio details for Sinovac
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Sinovac
Detailed financials for Sinovac
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Sinovac Comparisons
Peer comparison for Sinovac
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Sinovac
Sinovac operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Adaptive Biotechnologies, Moderna, Generate Biomedicines, HOOKIPA Pharma and Brii Biosciences, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Clinical diagnostics and drug discovery for immune diseases are provided.
|
|
| Locked | Locked | Locked |
mRNA-based therapeutics for diseases including cancer and infections are developed.
|
|
| Locked | Locked | Locked |
Developer of novel protein-based therapeutics using machine learning and biological engineering
|
|
| Locked | Locked | Locked |
Developer of immunotherapies for the treatment of infectious diseases and cancer
|
|
| Locked | Locked | Locked |
Developer of biologics to treat hepatitis B infection
|
|
| Locked | Locked | Locked |
VBI Vaccines is engaged in developing vaccines and immunotherapeutics.
|
Detailed competitors of Sinovac
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Sinovac
Complete news archive for Sinovac
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Sinovac
Sinovac was founded in 2001 and raised its 1st funding round 3 years after it was founded.
Sinovac is headquartered in Haidian, China. It is registered at Haidian, Beijing, China.
Sinovac was established in 2001 in Haidian, China, within the biotechnology sector focused on vaccine development. Vaccines have been produced for hepatitis A and B, seasonal influenza, H5N1 avian flu, H1N1 swine flu, mumps, and canine rabies. The Panflu.1 H1N1 vaccine was manufactured for the Chinese Central Government. Ongoing efforts include pipeline vaccines for enterovirus 71, pneumococcal conjugate and polysaccharides, and rubella, addressing key public health needs.
Sinovac's top competitors include Moderna, Adaptive Biotechnologies and Generate Biomedicines.
Sinovac has 6 investors. Key investors include Sino Biopharmaceutical, Advantech Capital, Vivo Capital, Ministry of Science and Technology of the People's Republic of China, and CBC Group.